Evidence map›Paper›PMID 41014092›Full record

ArticleJournal of veterinary internal medicine

Risk Factors for Pituitary Macrotumor in Dogs With Hypercortisolism.

Kei Yoshida, Yui Kobatake, Satoshi Takashima, Naohito Nishii

Abstract read
In one paragraph

Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kei YoshidaDolphin Animal Hospital Urawa Misono Clinic, Saitama, Japan.
Yui KobatakeJoint Department of Veterinary Medicine, Faculty of Applied Biological Science, Gifu University, Gifu, Japan.
Satoshi TakashimaJoint Department of Veterinary Medicine, Faculty of Applied Biological Science, Gifu University, Gifu, Japan.
Naohito NishiiJoint Department of Veterinary Medicine, Faculty of Applied Biological Science, Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0003-2173-5420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosing pituitary macrotumor in dogs with hypercortisolism requires advanced imaging, which is not feasible for every case. Identifying risk factors that can guide the decision to pursue imaging would be valuable.

objectiveDetermine clinical and physical examination findings that are associated with an increased likelihood of pituitary macrotumors in dogs with hypercortisolism. ANIMALS: A total of 130 dogs diagnosed with hypercortisolism.

methodsRetrospective study to analyze medical records for data on age, sex, breed, clinical signs, physical findings, endocrine test results, imaging results, diagnosis, and treatment. Logistic regression was used to identify risk factors for pituitary macrotumor, defined by a pituitary height/brain area ratio ≥ 0.4.

resultsRisk factors for pituitary macrotumor included diagnosis of hypercortisolism at ≤ 10.9 years of age (odds ratio [OR], 0.718; p < 0.05), French Bulldog breed (OR, 21.0; p < 0.01), and presence of neurologic signs (OR, 10.9; p < 0.001). CONCLUSION AND CLINICAL IMPORTANCE: Advanced pituitary imaging should be recommended in dogs with hypercortisolism ≤ 10.9 years of age, French Bulldogs, and those presenting with neurological signs because these factors significantly increase the likelihood of pituitary macrotumor in dogs with hypercortisolism.

Indexed as

Cushing SyndromeDog DiseasesPituitary NeoplasmsAdenomaAnimalsDogsFemaleMaleRetrospective StudiesRisk FactorscanineendocrinologyFrench bulldoghyperadrenocorticismpituitary macroadenoma

Identifiers

PMID41014092
PMCPMC12475908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.